Abstract
Several studies have shown that acarbose improves the metabolic control of type II diabetic patients when administered with sulfonylurea treatment. The aim of the present study was to evaluate the potential benefit of acarbose in association with sulfonylurea and biguanide. Twenty-eight patients (age, 51 ± 9 years; actual body weight, 119 ± 7% of IBW; duration of diabetes, 7.3 ± 1.4 years) with poorly controlled type II diabetes (fasting blood glucose > 7 mmol/L, postprandial value > 10 mmol/L) despite diet and maximal oral therapy (sulfonylurea plus biguanide) were included in the study.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rodier, M., Richard, J.L., Monnier, L., Mirouze, J. (1988). Metabolic Control in Type II Diabetes with Long-Term Acarbose Therapy: A Double-Blind Study. In: Creutzfeldt, W. (eds) Acarbose for the Treatment of Diabetes Mellitus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73583-7_35
Download citation
DOI: https://doi.org/10.1007/978-3-642-73583-7_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19145-2
Online ISBN: 978-3-642-73583-7
eBook Packages: Springer Book Archive